Assyro AI

Orange Book product · Brand (NDA)

PHENYLEPHRINE HYDROCHLORIDE

PHENYLEPHRINE HYDROCHLORIDE

Brand (NDA)NDA 203510TE ATRX PARAGON BIOTECK

At a glance

Mar 21, 2013

Approved

Brand (NDA)

Application

AT

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 21, 2013

    13 yr 5 mo ago

  2. Today

  3. Patent 8859623 expires

    Listed method-of-use patent (U-1594) expiration.

    Nov 14, 2033

    in 7 yr 6 mo

Pharmaceutical detail

Active ingredient

PHENYLEPHRINE HYDROCHLORIDE

Strength

2.5%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

AT

Application

NDA 203510

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8859623Nov 14, 2033in 7 yr 6 mo
U-1594
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.